Team Jumbo Vista at Tour de France 2022. Source: PDTeam Jumbo Vista at Tour de France 2022. Source: PD

Will the next Tour de France winner be a Supersapiens?

07.07.2022Craig Cooper

With tailor-made advice to nutrition our portfolio startup Supersapiens helps Tour de France teams like Jumbo Visma succeed. Here is how.

In order to win the biggest bike race in the world the Dutch team Jumbo Visma tries to improve every single aspect of a cyclist’s life. Nutrition plays a key role in that venture.

Here is where the Atlanta based startup Supersapiens comes into play. It developed a sensor which measures the user's glucose level. The real-time data end up in an app. These data can help athletes to choose their nutrition, to time it better and to consequently achieve training goals faster. Asker Jeukendrup, head of nutrition at Team Jumbo-Visma says that he can advise athletes very accurately thanks to the Supersapiens technology.

The American pro-cyclist Sepp Kuss using the Supersapiens technologyThe American pro-cyclist Sepp Kuss using the Supersapiens technology

Supersapiens uses the Abbott Libre Sense to stream glucose data in real time via Bluetooth. This allows pro athletes but also average users to get powerful insights. Glucose data can be used to get faster and stronger, to have more energy or to loose weight. The small biosensor is applied on the back of the upper arm.

Supersapiens was founded back in 2019 and is part of our Swiss Diabetes Venture Fund. The company has set the ambitious goal to become the most influential sports brand of this decade.

Founder and CEO Phil Southerland was diagnosed with Type 1 diabetes at 7-months old. Regardless of that he started a career as a professional cyclist where glucose control led to success in his sport. The experience he gained throughout the years then also led to the foundation of Supersapiens.

Similar Articles

17.06.2025

Redstone and Swiss Ventures Group join forces to democratize venture capital as an asset class in Switzerland

28.05.2025

LOXO Integrates Aeva’s 4D LiDAR for Safer Autonomy

29.04.2025

Arda Biomaterials Closes USD 5.25m Funding Round

01.04.2025

biped.ai Device Gains Public Reimbursement in France

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

Your cookie preferences have been saved.